Structure's obesity pill shows up to 16.3% weight loss in study

By Puyaan Singh and Sahil Pandey March 16 (Reuters) - Structure Therapeutics said on Monday its pill helped patients lose up to 16.3% of their weight, strengthening its bid to challenge Eli Lilly and Novo Nordisk in the increasingly competitive race to develop oral obesity drugs. Patients on Structure's once-daily pill, aleniglipron, lost up to 39 lbs on the 180 mg dose after 44 weeks, compared